The Diabetes Research Institute (DRI), a Center of Excellence at the University of Miami Miller School of Medicine, announced today that the first patient in its clinical trial has been free from insulin injections in record time following the implantation of islet cells within a biological scaffold. The patient, Wendy …
Read More »Managing Editor, Diabetes in Control
Smart Blood Glucose Meter to Help Diabetes Patients
Patients with diabetes have to monitor their blood glucose at home until the next doctor’s appointment. Smart blood glucose meter provides patients with easy access to certified diabetes educator and avoid future diabetes complications, according to Jodi Pulizzi, RN, BSN, CDE, CHC, director of clinical services for Livongo Health, based …
Read More »Increased Dietary Salt May be Correlated with Obesity
Consuming more salt, regardless of caloric consumption, can lead to obesity or being overweight. A study in the journal Hypertension reports that an increased intake of 1 g of sodium per day increases the risk of obesity by 28% in children and 26% in adults. In the UK and the …
Read More »Phase II Trials for Omarigliptin Prove Hopeful for Phase III Trials
Research was recently published inDiabetes Care as a Phase II study to determine optimal dosing, tolerability and efficacy of a new, once-weekly DPP-4 inhibitor called omarigliptin. Over 12 weeks, the researchers looked at HbA1C, 2-hour postprandial glucose and fasting glucose. Currently, the DPP-4 inhibitors on the market are all once-daily. …
Read More »Discontinuation of TZD Reduces Fracture Rates
Thiazolidinediones (TZDs), rosiglitazone and pioglitazone, have been shown to increase fracture risk in women after a year of TZD use; however, there has been little data available on the effects of the discontinuation of TZD. This longitudinal observational cohort study used data from an ancillary study of skeletal health within …
Read More »Finerenone Improves Albuminuria in Diabetic Nephropathy Patients
Mineralocorticoid receptor antagonists (MRAs) are often used with a renin-angiotensin system (RAS) blocker to further reduce proteinuria in patients with CKD. However, eplerenone and spironolactone increase the risk of hyperkalemia in these patients. Finerenone (BAY94-8862) is a new nonsteroidal MRA that has better receptor selectivity than spironolactone, associating with lower …
Read More »The Effects of Extra Virgin Olive Oil on Post-Prandial Glucose
A Mediterranean diet is considered to be ideal for healthy nutrition. It is typically composed of fruits, vegetables, cereals, fish, moderate wine consumption, and limited intake of dairy products and red meat. Furthermore, there are several studies showing that this type of diet is connected with reduced risk of cardiovascular …
Read More »Correlation Between Speed of Eating and Incidence of Metabolic Syndrome
In recent years, there has been a worldwide focus on metabolic syndrome to identify specific factors that may contribute to the development of diabetes and obesity. An interesting factor that researchers are exploring is eating habits, particularly, the speed of eating. Therefore, a study was performed to understand the relationship …
Read More »Safety and Efficacy of Vildagliptin and Sitagliptin in Renally Impaired Type 2 Diabetics
Dipeptidyl peptidase-4 (DPP4) inhibitors are generally well-tolerated for use in patients with severe renal impairment...
Read More »A Novel Formulation of Metformin May Increase the Drug’s Use
For newly diagnosed type 2 diabetes patients, metformin is the first-line drug of choice. It can be used alone, in combination with other oral antidiabetic drugs, or in addition to insulin. Its precise mechanism of action is as of yet unknown, but a new study published in Diabetes Care posits …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.